BIEL (Bioelectronics) Total Equity: $0.00 Mil (As of . 20)


What is Bioelectronics Total Equity?

Bioelectronics BIEL Total Equity is $0.00 Mil as of . 20.

Bioelectronics's total equity for the quarter that ended in . 20 was $0.00 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Bioelectronics Total Equity Historical Data

* Premium members only.

The historical data trend for Bioelectronics's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bioelectronics Total Equity Chart

Bioelectronics Annual Data
Trend
Total Equity

Bioelectronics Quarterly Data
Total Equity

Bioelectronics Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Bioelectronics's Total Equity for the fiscal year that ended in . 20 is calculated as

Total Equity=Total Assets(Q: . 20 )-Total Liabilities(Q: . 20 )
=N/A-N/A
=N/A

Bioelectronics's Total Equity for the quarter that ended in . 20 is calculated as

Total Equity=Total Assets(Q: . 20 )-Total Liabilities(Q: . 20 )
=N/A-N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of $0.00 Mil mean?
Bioelectronics (BIEL) has a Total Equity of $0.00 Mil as of . 20. The total amount of equity as record on a company's balance sheet. View historical data for Bioelectronics and its competitors.
Is Bioelectronics' Total Equity too high?
Bioelectronics' current Total Equity is $0.00 Mil.
How does Bioelectronics' Total Equity compare to NUVPF and ADMD?
Bioelectronics' Total Equity of $0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Medical Devices & Instruments company?
A good Total Equity depends on the Medical Devices & Instruments industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Bioelectronics and its competitors. Bioelectronics's current Total Equity is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bioelectronics stock overvalued right now?
Bioelectronics (BIEL) has a current Total Equity of $0.00 Mil. The current Total Equity is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Bioelectronics (BIEL), the current Total Equity is $0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bioelectronics Business Description

Address 3880 Roundtree Road, Suite 1, Jefferson, MD, USA, 21755
Bioelectronics Corp is an electroceutical company. The company develops wearable, neuromodulation devices to safely mitigate neurological diseases and improve quality of life. Its product line includes Actipatch Musculoskeletal Pain Therapy, Allay menstrual pain therapy, Smart insole heel pain therapy, and Recovery RX post operative and Chronic wounds therapy. It sells its products to wholesale distributors, directly to hospitals and clinics, and to consumers. develops & commercializes electrical stimulation/neuromodulation technology. Company products include RecoveryRx, ActiPatch Musculoskeletal Pain Relief, and Others.